Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma

Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms

(2015) Jahangir Abdi et al.   Oncotarget

Lipopolysaccharide Drives Alternation of Heat Shock Proteins and Induces Failure of Blastocyst Implantation in Mouse

(2013) M. K. Jaiswal et al.   BIOLOGY OF REPRODUCTION

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

(2013) U.-H. Mellqvist et al.   BLOOD

Plasma cell tumors in transplant patients

(2013) M. A. Nalesnik   BLOOD

Autologous retransplantation for patients with recurrent multiple myeloma

(2013) Leopold Sellner et al.   CANCER

WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell-depleted hematopoietic stem cell transplantation and donor lymphocyte infusions

(2012) E. M. Tyler et al.   BLOOD

Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity

(2012) S. Hong et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: A Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell Disorders

(2012) J. Bae et al.   CLINICAL CANCER RESEARCH

Hsp70 Protein Complexes as Drug Targets

(2012) Victoria A. Assimon et al.   CURRENT PHARMACEUTICAL DESIGN

An activated JAK/STAT3 pathway and CD45 expression are associated with sensitivity to Hsp90 inhibitors in multiple myeloma

(2012) Huiqiong Lin et al.   EXPERIMENTAL CELL RESEARCH

Arsenic Trioxide Exerts Antimyeloma Effects by Inhibiting Activity in the Cytoplasmic Substrates of Histone Deacetylase 6

(2012) Xiaoyan Qu et al.   PLoS One

Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders

(2011) Jooeun Bae et al.   BRITISH JOURNAL OF HAEMATOLOGY

Identification of novel myeloma-specific XBP1 peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma

(2011) J Bae et al.   LEUKEMIA

IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype

(2010) Jana Albrecht et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Antiviral CD8+T cell effector activities in situ are regulated by target cell type

(2010) Matthew M. Hufford et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Induction of Cellular Immune Responses in Patients With Stage-I Multiple Myeloma After Vaccination With Autologous Idiotype-pulsed Dendritic Cells

(2010) Christoph Röllig et al.   JOURNAL OF IMMUNOTHERAPY

Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma

(2009) J. Qian et al.   BLOOD